The declotting devices market size has grown strongly in recent years. It will grow from $2.26 billion in 2025 to $2.41 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to rising incidence of deep vein thrombosis and pulmonary embolism, increasing awareness of clot-related complications, growth in emergency vascular interventions, expansion of hospital-based interventional facilities, improved clinical outcomes of mechanical declotting techniques.
The declotting devices market size is expected to see strong growth in the next few years. It will grow to $3.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing prevalence of cardiovascular and thrombotic disorders, growing demand for rapid emergency interventions, rising adoption of minimally invasive vascular procedures, expansion of interventional radiology and cardiology centers, improving access to advanced thrombectomy devices. Major trends in the forecast period include rising adoption of minimally invasive declotting procedures, growing use of mechanical thrombectomy over pharmacological methods, increasing preference for rapid clot removal in emergency care, expansion of declotting procedures in acute vascular conditions, growing demand for precision and safety in thrombus removal.
The rising incidence of vascular disorders is expected to drive growth in the declotting devices market. Vascular disorders affect blood vessels such as arteries, veins, and capillaries disrupting normal blood flow and potentially leading to various health complications. The increasing prevalence of risk factors such as obesity, sedentary lifestyles, and aging populations is contributing to the rise in vascular disorders. Declotting devices are crucial in treating these conditions by rapidly and effectively removing or dissolving blood clots to restore normal blood flow and prevent complications.For example, in January 2025, according to the National Institutes of Health (NIH), a US-based agency under the Department of Health and Human Services, the global cost of stroke exceeds US$890 billion annually, representing approximately 0.66% of global GDP, and is projected to nearly double by 2050. Thus, the growing incidence of vascular disorders is propelling the declotting devices market.
Leading companies in the declotting devices market are focusing on developing advanced products, such as computer-aided declotting devices (thrombectomy), to improve precision and effectiveness in clot removal procedures. These advanced devices assist in the removal of blood clots from vessels. For instance, in June 2023, Penumbra Inc., a US-based medical device manufacturer, launched Lightning Bolt 7, an advanced arterial declotting (thrombectomy) system. This system introduces modulated aspiration and integrates Penumbra’s Lightning Intelligent Aspiration technology with an advanced microprocessor algorithm. The Lightning Bolt 7 is designed to swiftly extract large, fibrous arterial blood clots with minimal blood loss, addressing acute limb ischemia (ALI), hibernating thrombus, and visceral occlusions, thereby offering a significant advancement in declotting technology.
In April 2023, Abbott Laboratories, a US-based medical device company, acquired Cardiovascular Systems, Inc. for an undisclosed amount. This acquisition allows Abbott Laboratories to expand its vascular health portfolio by incorporating advanced atherectomy solutions for the treatment of arterial disease, enhancing Abbott's offerings in minimally invasive treatments for peripheral and coronary artery diseases. Cardiovascular Systems, Inc. is a US-based manufacturer of medical devices that primarily focuses on treating peripheral and coronary artery diseases.
Major companies operating in the declotting devices market are Medtronic plc, Stryker Corporation, Penumbra Inc, Boston Scientific Corporation, Terumo Corporation, Abbott Laboratories, Teleflex Incorporated, Argon Medical Devices Inc, B Braun Melsungen, Phenox GmbH, Acandis GmbH & Co KG, Rapid Medical Inc, AngioDynamics Inc, Imperative Care Inc, Balt Extrusion SAS, Vesalio LLC, Merit Medical Systems Inc, Natec Medical Ltd, Control Medical Technology LLC, Sino Medical Sciences Technology Inc.
North America was the largest region in the declotting devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the declotting devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the declotting devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the declotting devices market by increasing costs for imported catheters, precision mechanical components, and specialized manufacturing equipment used in thrombectomy and embolectomy devices. These impacts are most evident in mechanical declotting and aspiration thrombectomy segments, with asia-pacific and europe experiencing higher exposure due to reliance on global supply chains. Increased tariffs have raised procurement costs for hospitals and clinics, slowing replacement cycles. However, tariffs have also encouraged regional manufacturing, supplier diversification, and local sourcing strategies, supporting long-term market resilience.
The declotting devices market research report is one of a series of new reports that provides declotting devices market statistics, including declotting devices industry global market size, regional shares, competitors with a declotting devices market share, detailed declotting devices market segments, market trends and opportunities, and any further data you may need to thrive in the declotting devices industry. This declotting devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Declotting devices are medical instruments designed to remove blood clots (thrombi) from blood vessels in emergency situations where clotting obstructs normal blood flow. These devices are used in conditions such as deep vein thrombosis (DVT), where clots can lead to severe complications such as pulmonary embolism.
The primary types of declotting devices include mechanical declotting devices and embolectomy balloons. A mechanical declotting device is designed to eliminate blood clots from blood vessels through mechanical methods, aiming to restore normal blood flow and prevent complications in conditions such as deep vein thrombosis or pulmonary embolism. Declotting devices encompass thrombectomy devices, such as aspiration thrombectomy devices, percutaneous mechanical thrombectomy devices, and others, and are used in various settings, including hospitals, clinics, and more.
The declotting devices market consists of sales of ultrasound-assisted thrombolysis devices, hemolytic embolectomy devices, and rotational embolectomy devices. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The declotting devices market size is expected to see strong growth in the next few years. It will grow to $3.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing prevalence of cardiovascular and thrombotic disorders, growing demand for rapid emergency interventions, rising adoption of minimally invasive vascular procedures, expansion of interventional radiology and cardiology centers, improving access to advanced thrombectomy devices. Major trends in the forecast period include rising adoption of minimally invasive declotting procedures, growing use of mechanical thrombectomy over pharmacological methods, increasing preference for rapid clot removal in emergency care, expansion of declotting procedures in acute vascular conditions, growing demand for precision and safety in thrombus removal.
The rising incidence of vascular disorders is expected to drive growth in the declotting devices market. Vascular disorders affect blood vessels such as arteries, veins, and capillaries disrupting normal blood flow and potentially leading to various health complications. The increasing prevalence of risk factors such as obesity, sedentary lifestyles, and aging populations is contributing to the rise in vascular disorders. Declotting devices are crucial in treating these conditions by rapidly and effectively removing or dissolving blood clots to restore normal blood flow and prevent complications.For example, in January 2025, according to the National Institutes of Health (NIH), a US-based agency under the Department of Health and Human Services, the global cost of stroke exceeds US$890 billion annually, representing approximately 0.66% of global GDP, and is projected to nearly double by 2050. Thus, the growing incidence of vascular disorders is propelling the declotting devices market.
Leading companies in the declotting devices market are focusing on developing advanced products, such as computer-aided declotting devices (thrombectomy), to improve precision and effectiveness in clot removal procedures. These advanced devices assist in the removal of blood clots from vessels. For instance, in June 2023, Penumbra Inc., a US-based medical device manufacturer, launched Lightning Bolt 7, an advanced arterial declotting (thrombectomy) system. This system introduces modulated aspiration and integrates Penumbra’s Lightning Intelligent Aspiration technology with an advanced microprocessor algorithm. The Lightning Bolt 7 is designed to swiftly extract large, fibrous arterial blood clots with minimal blood loss, addressing acute limb ischemia (ALI), hibernating thrombus, and visceral occlusions, thereby offering a significant advancement in declotting technology.
In April 2023, Abbott Laboratories, a US-based medical device company, acquired Cardiovascular Systems, Inc. for an undisclosed amount. This acquisition allows Abbott Laboratories to expand its vascular health portfolio by incorporating advanced atherectomy solutions for the treatment of arterial disease, enhancing Abbott's offerings in minimally invasive treatments for peripheral and coronary artery diseases. Cardiovascular Systems, Inc. is a US-based manufacturer of medical devices that primarily focuses on treating peripheral and coronary artery diseases.
Major companies operating in the declotting devices market are Medtronic plc, Stryker Corporation, Penumbra Inc, Boston Scientific Corporation, Terumo Corporation, Abbott Laboratories, Teleflex Incorporated, Argon Medical Devices Inc, B Braun Melsungen, Phenox GmbH, Acandis GmbH & Co KG, Rapid Medical Inc, AngioDynamics Inc, Imperative Care Inc, Balt Extrusion SAS, Vesalio LLC, Merit Medical Systems Inc, Natec Medical Ltd, Control Medical Technology LLC, Sino Medical Sciences Technology Inc.
North America was the largest region in the declotting devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the declotting devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the declotting devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the declotting devices market by increasing costs for imported catheters, precision mechanical components, and specialized manufacturing equipment used in thrombectomy and embolectomy devices. These impacts are most evident in mechanical declotting and aspiration thrombectomy segments, with asia-pacific and europe experiencing higher exposure due to reliance on global supply chains. Increased tariffs have raised procurement costs for hospitals and clinics, slowing replacement cycles. However, tariffs have also encouraged regional manufacturing, supplier diversification, and local sourcing strategies, supporting long-term market resilience.
The declotting devices market research report is one of a series of new reports that provides declotting devices market statistics, including declotting devices industry global market size, regional shares, competitors with a declotting devices market share, detailed declotting devices market segments, market trends and opportunities, and any further data you may need to thrive in the declotting devices industry. This declotting devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Declotting devices are medical instruments designed to remove blood clots (thrombi) from blood vessels in emergency situations where clotting obstructs normal blood flow. These devices are used in conditions such as deep vein thrombosis (DVT), where clots can lead to severe complications such as pulmonary embolism.
The primary types of declotting devices include mechanical declotting devices and embolectomy balloons. A mechanical declotting device is designed to eliminate blood clots from blood vessels through mechanical methods, aiming to restore normal blood flow and prevent complications in conditions such as deep vein thrombosis or pulmonary embolism. Declotting devices encompass thrombectomy devices, such as aspiration thrombectomy devices, percutaneous mechanical thrombectomy devices, and others, and are used in various settings, including hospitals, clinics, and more.
The declotting devices market consists of sales of ultrasound-assisted thrombolysis devices, hemolytic embolectomy devices, and rotational embolectomy devices. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Declotting Devices Market Characteristics
3. Declotting Devices Market Supply Chain Analysis
4. Global Declotting Devices Market Trends and Strategies
5. Declotting Devices Market Analysis of End Use Industries
7. Global Declotting Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Declotting Devices Total Addressable Market (TAM) Analysis for the Market
9. Declotting Devices Market Segmentation
10. Declotting Devices Market Regional and Country Analysis
11. Asia-Pacific Declotting Devices Market
12. China Declotting Devices Market
13. India Declotting Devices Market
14. Japan Declotting Devices Market
15. Australia Declotting Devices Market
16. Indonesia Declotting Devices Market
17. South Korea Declotting Devices Market
18. Taiwan Declotting Devices Market
19. South East Asia Declotting Devices Market
20. Western Europe Declotting Devices Market
21. UK Declotting Devices Market
22. Germany Declotting Devices Market
23. France Declotting Devices Market
24. Italy Declotting Devices Market
25. Spain Declotting Devices Market
26. Eastern Europe Declotting Devices Market
27. Russia Declotting Devices Market
28. North America Declotting Devices Market
29. USA Declotting Devices Market
30. Canada Declotting Devices Market
31. South America Declotting Devices Market
32. Brazil Declotting Devices Market
33. Middle East Declotting Devices Market
34. Africa Declotting Devices Market
36. Declotting Devices Market Competitive Landscape and Company Profiles
37. Declotting Devices Market Other Major and Innovative Companies
40. Declotting Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Declotting Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses declotting devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for declotting devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The declotting devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Mechanical Declotting Device; Embolectomy Balloon2) By Thrombectomy Device: Aspiration Thrombectomy Devices; Percutaneous Mechanical Thrombectomy Devices; Other Thrombectomy Devices
3) By End Use: Hospitals; Clinics; Other End Uses
Subsegments:
1) By Mechanical Declotting Device: Thrombectomy Devices; Rotational Thrombectomy Devices; Aspiration Catheters; Stent Retriever Devices; Rotational And Suction-Based Thrombectomy Devices2) By Embolectomy Balloon: Single-Lumen Embolectomy Balloon; Dual-Lumen Embolectomy Balloon; High-Pressure Embolectomy Balloons; Low-Pressure Embolectomy Balloons
Companies Mentioned: Medtronic plc; Stryker Corporation; Penumbra Inc; Boston Scientific Corporation; Terumo Corporation; Abbott Laboratories; Teleflex Incorporated; Argon Medical Devices Inc; B Braun Melsungen; Phenox GmbH; Acandis GmbH & Co KG; Rapid Medical Inc; AngioDynamics Inc; Imperative Care Inc; Balt Extrusion SAS; Vesalio LLC; Merit Medical Systems Inc; Natec Medical Ltd; Control Medical Technology LLC; Sino Medical Sciences Technology Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Declotting Devices market report include:- Medtronic plc
- Stryker Corporation
- Penumbra Inc
- Boston Scientific Corporation
- Terumo Corporation
- Abbott Laboratories
- Teleflex Incorporated
- Argon Medical Devices Inc
- B Braun Melsungen
- Phenox GmbH
- Acandis GmbH & Co KG
- Rapid Medical Inc
- AngioDynamics Inc
- Imperative Care Inc
- Balt Extrusion SAS
- Vesalio LLC
- Merit Medical Systems Inc
- Natec Medical Ltd
- Control Medical Technology LLC
- Sino Medical Sciences Technology Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.41 Billion |
| Forecasted Market Value ( USD | $ 3.1 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
